The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
994
Safety of Calcium-Channel Blockers
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Safety of Calcium-Channel Blockers
Reports of increased mortality associated with calcium-channel blockers have caused concerns among patients taking these drugs and their physicians.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Safety of Calcium-Channel Blockers
Article code: 994a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.